Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 99 336127 036153 608193 666--
Entreprise Value (EV)1 117 650142 516167 607205 460202 590199 228
P/E ratio 285x55,2x42,2x44,6x34,7x32,4x
Yield 1,88%1,60%1,52%1,32%1,43%1,55%
Capitalization / Revenue 3,63x4,15x4,81x5,72x5,05x4,90x
EV / Revenue 4,30x4,66x5,25x6,07x5,28x5,04x
EV / EBITDA 16,8x14,5x20,5x22,9x18,6x17,3x
Price to Book 3,22x4,16x4,92x4,76x4,34x4,01x
Nbr of stocks (in thousands) 1 740 6011 756 3331 768 4561 772 362--
Reference price (USD) 57,172,386,9109109109
Last update 01/24/201801/23/201901/22/202011/19/202011/19/202011/19/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 27 39030 57831 90433 87338 37039 555
EBITDA1 7 0229 8338 1888 97210 91011 484
Operating profit (EBIT)1 5 9766 5557 1107 8419 5839 982
Operating Margin 21,8%21,4%22,3%23,1%25,0%25,2%
Pre-Tax Profit (EBT)1 2 2312 8734 0774 0524 6595 832
Net income1 3532 3343 6874 4155 8076 366
Net margin 1,29%7,63%11,6%13,0%15,1%16,1%
EPS2 0,201,312,062,453,153,37
Dividend per Share2 1,081,161,321,441,561,70
Last update 01/24/201801/23/201901/22/202011/19/202011/19/202011/19/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 18 31415 48013 99911 7948 9245 562
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,61x1,57x1,71x1,31x0,82x0,48x
Free Cash Flow1 4 4354 9064 4984 5097 3097 922
ROE (Net Profit / Equities) 17,1%16,7%18,9%16,7%17,7%17,9%
Shareholders' equity1 2 06313 97019 54926 40632 79135 637
ROA (Net Profit / Asset) 6,83%7,16%8,60%7,30%8,38%9,19%
Assets1 5 17132 62042 85460 45969 27769 244
Book Value Per Share2 17,717,417,623,025,227,3
Cash Flow per Share2 3,183,563,453,665,055,56
Capex1 1 0001 3941 6381 8071 9562 032
Capex / Sales 3,65%4,56%5,13%5,33%5,10%5,14%
Last update 01/24/201801/23/201901/22/202010/22/202010/22/202010/22/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
193 665 949 955
Net sales (USD)
31 904 000 000
Number of employees
107 000
Sales / Employee (USD)
298 168
Free-Float
88,9%
Free-Float capitalization (USD)
172 083 921 044
Avg. Exchange 20 sessions (USD)
590 531 677
Average Daily Capital Traded
0,30%
EPS & Dividend